208 related articles for article (PubMed ID: 2068162)
1. A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy.
Rutgers M; Gubbels AA; Hoefnagel CA; Voûte PA; Smets LA
Prog Clin Biol Res; 1991; 366():471-8. PubMed ID: 2068162
[No Abstract] [Full Text] [Related]
2. SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice.
Clerc J; Halpern S; Fourré C; Omri F; Briançon C; Jeusset J; Fragu P
J Nucl Med; 1993 Sep; 34(9):1565-70. PubMed ID: 8355077
[TBL] [Abstract][Full Text] [Related]
3. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic use of I-131-MIBG in nude mice hosting human neuroblastoma xenografts.
Senekowitsch R; Laubenbacher C; Möllenstädt S; Kriegel H; Pabst HW
Strahlenther Onkol; 1989 Jul; 165(7):566-8. PubMed ID: 2749502
[No Abstract] [Full Text] [Related]
5. Pharmacokinetics and efficacy of 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts.
Gaze MN; Hamilton TG; Mairs RJ
Br J Radiol; 1994 Jun; 67(798):573-8. PubMed ID: 8032811
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.
O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
Prog Clin Biol Res; 1991; 366():455-61. PubMed ID: 2068160
[No Abstract] [Full Text] [Related]
7. Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [131I]meta-iodobenzylguanidine: implications for the targeted radiotherapy of neuroblastoma.
Mairs RJ; Russell J; Cunningham S; O'Donoghue JA; Gaze MN; Owens J; Vaidyanathan G; Zalutsky MR
Eur J Cancer; 1995; 31A(4):576-81. PubMed ID: 7576972
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma-induced differentiation of human neuroblastoma cells increases cellular uptake and halflife of metaiodobenzylguanidine.
Montaldo PG; Carbone R; Cornaglia Ferraris P; Ponzoni M
Cytotechnology; 1993; 11 Suppl 1():S140-3. PubMed ID: 7763744
[TBL] [Abstract][Full Text] [Related]
9. Model studies on metaiodobenzylguanidine (MIBG) uptake and storage: relevance for 131I-MIBG therapy of neuroblastoma.
Smets LA; Rutgers M
J Nucl Biol Med (1991); 1991; 35(4):191-4. PubMed ID: 1823816
[No Abstract] [Full Text] [Related]
10. Session on the biology and treatment of neuroblastoma as related to metaiodobenzylguanidine. Chairmen's report.
Sisson JC; De Bernardi B
J Nucl Biol Med (1991); 1991; 35(4):199-201. PubMed ID: 1823818
[No Abstract] [Full Text] [Related]
11. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
12. Distribution of m-IBG in nude mice bearing LAN-5 neuroblastoma xenografts and in vitro cell culture.
Van der Wall H; Durbidge M; White L; Taylor D; Murray IP
In Vivo; 1991; 5(2):123-6. PubMed ID: 1768781
[TBL] [Abstract][Full Text] [Related]
13. Implications of the uptake of 131I-radiolabelled meta-iodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma.
O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
Br J Radiol; 1991 May; 64(761):428-34. PubMed ID: 2036567
[TBL] [Abstract][Full Text] [Related]
14. [131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma.
Hoefnagel CA; Voûte PA; De Kraker J; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):202-6. PubMed ID: 1823819
[TBL] [Abstract][Full Text] [Related]
15. Can preirradiation enhance tumor uptake of radiolabeled pharmaceuticals? Experimental data in a mouse neuroblastoma xenograft system.
Sautter-Bihl ML; Bihl H
Recent Results Cancer Res; 1996; 141():123-35. PubMed ID: 8722423
[No Abstract] [Full Text] [Related]
16. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
[TBL] [Abstract][Full Text] [Related]
17. [131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.
Klingebiel T; Treuner J; Ehninger G; Keller KD; Dopfer R; Feine U; Niethammer D
Cancer Chemother Pharmacol; 1989; 25(2):143-8. PubMed ID: 2598401
[TBL] [Abstract][Full Text] [Related]
18. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
19. A human neuroblastoma xenograft model for 125-I-metaiodobenzylguanidine biodistribution studies.
Lavitrano M; Servidei T; Mastrangelo S; Tornesello A; Fioretti D; Di Stefano C; Riccardi A; Franceschini R; Riccardi R
J Neurooncol; 1997 Jan; 31(1-2):159-64. PubMed ID: 9049844
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
Weber W; Weber J; Senekowitsch-Schmidtke R
Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
